Medindia

X

Amilpar - Press Release - Commercial Papers

Saturday, December 12, 2009 Press Release J E 4
Advertisement
RIO DE JANEIRO, Dec. 11 Amilpar (Bovespa: AMIL3;Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managedcare organization in Brazil, in accordance with CVM (Brazilian Securities andExchange Commission) Instruction 358/02, informs that the 1st Issuance ofCommercial Papers for public distribution with restricted selling efforts(according to CVM Instruction 476/09), was approved in a Board Meeting heldtoday, with the objective of increasing the Company's cash position after theacquisition of Medial Saude S.A. control, under the following terms andconditions:Total Amount: R$ 300 million Term: 360 days, with the option of anticipating redemption Remuneration: 110% of CDI (average interbank deposit rate in Brazil) Coordinator: Banco Bradesco BBI S.A. To access the Press Release visit our website at www.amilpar.com.br/ir IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 invest@amil.com.br www.amilpar.com.br/ir

SOURCE Amilpar
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
EntreMed Reports Receipt of Third Quarter Royalty ...
S
Two Prominent Massachusetts Nurse Activists Assume...